angioplasty News

Heart catheterization labs housed within Baptist Cardiac & Vascular Institute and South Miami Heart Center, both part of Baptist Health South Florida, are the first in Florida to receive accreditation.

To earn the award, South Nassau needed to adhere to the treatment guidelines in ACTION Registry–GWTG for 12 consecutive quarters (three years) and meet a performance standard of at least 85% for specific performance measures.

Board-certified in cardiovascular diseases and internal medicine, Dr. Rehman has been an attending cardiologist at SNCH since 2002. He is a fellow of the American College of Cardiology and Society for Cardiovascular Angiography and Intervention.

Paul Chan, M.D., study suggests overuse of elective procedures creates opportunity to improve decision making, selection criteria

The grant will support the construction of a new electrophysiology laboratory and procedure room for diagnostic studies to determine the source of arrhythmia symptoms and to perform treatment procedures.

South Nassau Communities Hospital has been awarded a Gold Performance Achievement Award in Coronary Artery Disease from the American Heart Association/American Stroke Association's Get with the Guidelines program.

The number of patients awaiting angioplasty in western world is on rise. India through its state of the art health infrastructure and skilled manpower provides great option for such patients

The Bank of America Charitable Foundation has awarded a $500,000 grant to South Nassau Communities Hospital in support of the hospital’s Center for Cardiovascular Health and its program for medically underserved individuals.

White Plains Hospital Center’s Cardiac Catheterization Laboratory has received approval from the New York State Department of Health to provide emergency and elective angioplasty, a minimally invasive procedure to restore blood flow to the heart.

Medical Travel and healthcare competition from abroad is a wake-up call for all parties involved in the healthcare coverage debate, from policy makers to healthcare providers, and from insurers to patients.

The coronary stents market is dominated by drug-eluting stents, but the market for anti-restenosis has proven dynamic due to many active companies with diverse technologies targeting this area of cardiovascular treatment.

The global coronary stent market faces continued growth, development and competition from a wide range of technology types and competitors. The market is detailed in a new report from MedMarket Diligence.

A study showed that heart attack patients treated with balloon angioplasty within 90 minutes had a higher rate of survival than those who waited more than 90 minutes to receive the procedure.

Vancouver, Canada, June 19th, 2009 - Symbiorph Biomedical Corporation is pleased to announce that it has received CE mark approval for the enhancement in profile and size range of its SYMTREK™ rapid exchange coronary dilatation catheter.

Treatment of coronary artery disease has become a hotbed for evaluation of an incredible range of alternatives, but drug-eluting stents (DES) clearly represent the most attractive option, according to a new report from MedMarket Diligence (MMD).

The market for coronary stents worldwide is well established, large and still demonstrating excellent growth, especially with the advent of new technologies from established and hopeful competitors, according to a new report from MedMarket Diligence.

Coronary artery disease is addressed by a range alternative treatment methodologies; percutaneous intervention with or without stenting, coronary artery bypass grafting alternatives and other options, but stents represent the fastest growing option.

TITUSVILLE, FL (January 22, 2009)—The State of Florida Agency for Health Care Administration (AHCA), which regulates hospital services, has granted Parrish Medical Center (PMC) approval to perform elective coronary angioplasty and stenting.